Related Experiment Videos

Recurrence of cervical carcinoma manifesting as cardiac metastasis three years after curative resection

Kyoko Inamura1, Akihiro Hayashida, Yoshikazu Kaji

  • 1Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Higashi-ku, Fukuoka, Japan.

Insights

Late cardiac metastasis from cervical cancer is rare but possible, even after successful treatment. This case highlights the importance of considering heart involvement in patients with a history of cervical carcinoma.

Area of Science:

  • Oncology
  • Cardiology
  • Pathology

Background:

  • Uterine cervical carcinoma is a common gynecologic malignancy.
  • Cardiac metastasis is an infrequent complication of various cancers.
  • Late recurrence after curative treatment necessitates ongoing surveillance.

Observation:

  • A 58-year-old woman with a history of stage IB1 cervical carcinoma presented with pulmonary emboli, disseminated intravascular coagulation, and right heart failure.
  • Imaging revealed large tumors in the right ventricle and pulmonary artery, with no evidence of pelvic or abdominal recurrence.
  • Surgical tumor removal provided temporary symptomatic improvement.

Findings:

  • The patient experienced a recurrence of the right ventricular tumor four months post-surgery.
  • Death occurred due to progressive heart failure secondary to tumor recurrence.
  • Histopathological confirmation of cardiac metastasis from the original cervical carcinoma.

Implications:

  • This case underscores the potential for late cardiac metastasis from cervical cancer.
  • Clinicians should maintain a high index of suspicion for cardiac involvement in patients with a history of cervical cancer presenting with cardiopulmonary symptoms.
  • Further research into the mechanisms and optimal management of rare metastatic patterns is warranted.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...